Citation:Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, et al 2011
From Cancer Guidelines Wiki
Citation
Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 2011 Sep 17;378(9796):1079-88 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21831418.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:Which new agent or platinum combination regimen is best for treatment of stage IV inoperable NSCLC?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Which new agent or platinum combination regimen is best for treatment of stage IV inoperable NSCLC?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?</span></span></span></span>»]] (compare critical appraisals)